Many R&D tablet presses claim to “simulate production.” But simulation only goes so far. What pharmaceutical scientists and process engineers actually need is real compression data collected at true production velocities – data that reflects powder flow behavior, compaction characteristics, and the actual impact of a production press on the final tablet. That’s exactly what the Natoli NP-RD30 with AIM Pro delivers.
Instead of estimating scale-up performance, the RD30 measures it directly. It captures how a formulation behaves under real punch velocity, real dwell time, real powder consolidation conditions, and real feeder performance. The result is analytical data that reflects what will happen on a full-scale production press – not what might happen.
Many systems treat USP <1062>tablet characterization as an afterthought. AIM Pro integrates it directly into the platform, allowing scientists to generate tabletability, compressibility, compactibility, and strain-rate profiles instantly – without extra software or data manipulation. The focus shifts from processing data to understanding formulation behavior.
While some platforms prioritize displacement accuracy, production testing, or benchtop flexibility, the NP-RD30 is engineered specifically to achieve realistic production press compression while capturing high-resolution analytical data. The result isn’t just lab data – it’s data that predicts manufacturing performance.
The NP-RD30 with AIM Pro is used in pharmaceutical, nutraceutical, contract manufacturing, veterinary pharmaceutical, and industrial environments where development decisions depend on reliable compaction data. From early-stage formulation screening to scale-up studies and clinical batch preparation, it provides the analytical clarity teams need to move forward faster and with more confidence.
Generate data that reflects true production performance.